Sm. Baumgartner-parzer et al., Mutational spectrum of the steroid 21-hydroxylase gene in Austria: Identification of a novel missense mutation, J CLIN END, 86(10), 2001, pp. 4771-4775
This study attempted an analysis of the mutational spectrum of 21-hydroxyla
se deficiency in 79 unrelated Austrian patients with classical and nonclass
ical forms of congenital adrenal hyperplasia and their respective 112 famil
y members. Apparent large gene deletions/conversions were present in 31% of
the 158 unrelated congenital adrenal hyperplasia alleles, whereas the most
frequent point mutations were intron 2 splice (22.8%),I172N (15.8%), V281L
(12%), and P30L (7.6%), in line with the frequencies reported for other co
untries. In 5 of the 12 congenital adrenal hyperplasia alleles carrying a P
30L mutation the aberration is based on a single base substitution, whereas
the remaining 7 represent part of a CYP21B conversion (I allele) or CYP21B
/21A hybrid gene (6 alleles), the latter characterized by a junction site b
efore intron 2 as indicated by Southern blot, PCR, and sequence analyses.
Previously described mutations were not present in 1.2% of unrelated congen
ital adrenal hyperplasia alleles, including one female patient presenting w
ith severe genital virilization. Sequence analysis of the complete function
al 21-hydroxylase gene revealed an as yet undescribed mutation in exon 10-A
rg(426)His, which has not yet been described to represent a common pseudoge
ne sequence. In vitro expression experiments showed the Arg(426)His Mutant
to exhibit only low enzyme activity toward the natural substrate 17-hydroxy
progesterone corresponding to the degree of disease manifestation in the pa
tient in whom it was found.